Search research articles
Contact Us
Filters
Showing results (231-240 of 330) with videos related to
Page
of 33
Sort By:
Targeted Oncology
|
October 17, 2020
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Tareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, et al.
Science Immunology
|
August 2, 2017
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Saleh Rachidi, Alessandra Metelli, Brian Riesenberg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 11, 2014
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer
Nestor F Esnaola, Uzair B Chaudhary, Paul O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2017
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
Carolyn D Britten, Elizabeth Garrett-Mayer, Steven H Chin, et al.
Journal of Oncology Practice
|
August 23, 2018
Understanding the Role of Advanced Practice Providers in Oncology in the United States
Suanna S Bruinooge, Todd A Pickard, Wendy Vogel, et al.
Journal of the Advanced Practitioner in Oncology
|
June 13, 2019
Understanding the Role of Advanced Practice Providers in Oncology in the United States
Suanna S Bruinooge, Todd A Pickard, Wendy Vogel, et al.
JCO Oncology Practice
|
September 20, 2022
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer
Rachel B Jimenez, Caroline Schenkel, Laura A Levit, et al.
JCO Oncology Practice
|
April 25, 2022
Hematology/Oncology Fellowship Programs' Participation in the Quality Oncology Practice Initiative
Issam Makhoul, Michael Anders, Robert Siegel, et al.
JCO Precision Oncology
|
February 8, 2023
Olaparib in Patients With Metastatic Prostate Cancer With <i>BRCA1</i>/<i>2</i> Mutation: Results From the TAPUR Study
Eddy S Yang, Susan Halabi, Michael Rothe, et al.
Leukemia Research
|
February 12, 2008
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes
Erica D Warlick, Paul V O'Donnell, Michael Borowitz, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 330) with videos related to
Sort By:
Page
of 33
Targeted Oncology
|
October 17, 2020
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Tareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, et al.
Science Immunology
|
August 2, 2017
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Saleh Rachidi, Alessandra Metelli, Brian Riesenberg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 11, 2014
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer
Nestor F Esnaola, Uzair B Chaudhary, Paul O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2017
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
Carolyn D Britten, Elizabeth Garrett-Mayer, Steven H Chin, et al.
Journal of Oncology Practice
|
August 23, 2018
Understanding the Role of Advanced Practice Providers in Oncology in the United States
Suanna S Bruinooge, Todd A Pickard, Wendy Vogel, et al.
Journal of the Advanced Practitioner in Oncology
|
June 13, 2019
Understanding the Role of Advanced Practice Providers in Oncology in the United States
Suanna S Bruinooge, Todd A Pickard, Wendy Vogel, et al.
JCO Oncology Practice
|
September 20, 2022
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer
Rachel B Jimenez, Caroline Schenkel, Laura A Levit, et al.
JCO Oncology Practice
|
April 25, 2022
Hematology/Oncology Fellowship Programs' Participation in the Quality Oncology Practice Initiative
Issam Makhoul, Michael Anders, Robert Siegel, et al.
JCO Precision Oncology
|
February 8, 2023
Olaparib in Patients With Metastatic Prostate Cancer With <i>BRCA1</i>/<i>2</i> Mutation: Results From the TAPUR Study
Eddy S Yang, Susan Halabi, Michael Rothe, et al.
Leukemia Research
|
February 12, 2008
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes
Erica D Warlick, Paul V O'Donnell, Michael Borowitz, et al.
Page
of 33